The Australian Paediatric Endocrine Care (APEC) Research Grants are awarded for the purpose of advancing clinical research in the field of Paediatric Endocrinology, and associated areas.

APEC Grants are designed to encourage young researchers to enter or continue in the field of Paediatric Endocrinology. Therefore, applicants must be under 40 years of age at the time of applying and a trainee in Paediatric Endocrinology in Australasia or within 5 years of conferring of FRACP or within 5 years of accreditation of Paediatric Endocrinology training from the Endocrinology SAC (Royal Australian College of Physicians). Applications will not be accepted from senior researchers.

Successful applicants would be expected to conduct their research within Paediatric Endocrinology Units within Australasia.

Grants will be awarded for one year.

Funding for APEC Grants will be up to $55,000 (including GST) per annum and will be awarded to cover part salaries, equipment, research materials and expenses.

Grant recipients must notify the APEC Grant Coordinator of any other funding obtained (or applied for) during the duration of the grant. Only one APEC Grant will be allocated to a single applicant in a given year although applications will be accepted and reviewed for more than one project. Applicants will not be eligible to receive funding from more than one Pfizer Australia, research grants program in the same financial year.

The applicant must indicate in their grant application under the ‘budget’ section what proportion of the proposal will be covered by the grant and if other funding is being received for the proposal then details must be entered as to where from, e.g. existing NH&MRC grant or other philanthropic grants.

Applications for the research grants will be reviewed by two independent reviewers and by the Australian Physicians Independent Committee (APIC), which is composed of leading clinicians and researchers from around the country. Pfizer will also review proposals involving any Pfizer compounds. The APIC is responsible for independent objective evaluation and recommendations of funding proposals for research projects. All decisions of the APIC are final and no correspondence will be entered into.

All personal information provided in your application, project summary and assessment details will be kept by the APEC Grant Coordinator, Pfizer Australia Pty Ltd and only be used for the purposes of administering this application, and if successful, the grant. Applicants personal information will be disclosed to reviewers as noted above. Applicants have the right to access their personal information at any time. If you wish to do this please contact the Grant Coordinator. The details of all successful applications will be published on the APEC website.

The funding is not being used to influence or reward the recipient for present, past or future use or support of Pfizer medicines or to influence the outcome of clinical trials.

If you are a successful recipient you will be required to provide Pfizer Australia with a tax invoice inclusive of GST from your academic or medical institution. This tax invoice must include the institutions’ ABN.

The application must be submitted via the online application form which can be accessed on the Pfizer Grants website.

If you have any questions regarding the completion of the application form please contact Trudy Snape on (02) 9850 3973.

Contact details:

APEC Grant Coordinator
Pfizer Australia
Medical Department
38-42 Wharf Road
West Ryde NSW 2114

Tel: (02) 9850 3973

Email: trudy.snape@pfizer.com

Website: www.pfizergrants.com.au

Required Documents:

• Completed Grant Application Form
• Study Proposal
• CV – Principal Investigator only
• Publication list
• A letter from supervisor or department head supporting the project
• Approval letter from Institutional Ethics Committee and Drug Sub-Committee, if applicable (funding will not be granted until the ethics approval letter has been received by the APEC Grant Coordinator)

APEC grants are awarded with the expectation that timely submissions for presentation will be made at appropriate medical meetings or research forums and that papers will be submitted for publication in appropriate peer-reviewed medical journals. The grant recipients will be required to provide Pfizer with an opportunity to review any proposed publications. A copy of all published papers must be sent to the APEC Grant Coordinator. Furthermore, Pfizer Australia will be acknowledged for sponsoring the research.

It is a requirement of APEC Research Grants that protocols that receive funding are not altered following the review process.

We understand that applicants may apply for funding from other sources. Please inform the APEC Grant Coordinator if you do receive funding prior to grants being awarded.

Twelve months after receiving funding support grant recipients will be required to provide a 500-word research summary to the APEC Grant Coordinator.

Pfizer Australia reserves the right to publicise the names of the grant recipients, their institutions, titles and summaries of their research projects, following consultation with the APIC.

All decisions made by the APIC are final.